Related Experiment Video
Updated: Jun 25, 2026
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Robotically enhanced coronary artery bypass grafting: the feasibility and clinical outcome of 196 procedures
Baris Caynak1, Ertan Sagbas, Burak Onan
1Department of Cardiovascular Surgery, Istanbul Bilim University, Florence Nightingale Hospital, Istanbul, Turkey. caynakbaris@hotmail.com
Insights
Robotically enhanced coronary artery bypass grafting (CABG) is a safe and effective procedure for single or multivessel coronary disease. This minimally invasive approach offers excellent outcomes, including high graft patency and freedom from ischemic symptoms.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Assessing the feasibility and clinical outcomes of robotically enhanced myocardial revascularization.
- Evaluating 196 patients undergoing robotic-assisted coronary artery bypass grafting (CABG).
Purpose of the Study:
- To determine the feasibility of robotically enhanced myocardial revascularization.
- To report the clinical outcomes of patients undergoing this procedure.
Main Methods:
- Robotic harvesting of internal thoracic arteries.
- Off-pump revascularization techniques, with peripheral cardiopulmonary bypass for multivessel disease.
- Surgical procedures for single (n=118) and multivessel (n=74) coronary revascularization.
Main Results:
- No operative mortality observed in 196 patients.
- High rate of freedom from ischemic symptoms (98.2%) at a mean follow-up of 22 months.
- Excellent graft patency rate of 96.4% (81/84).
Conclusions:
- Robotically enhanced CABG is a safe and effective treatment for single and multivessel coronary disease.
- This approach expands surgical capabilities and can be an alternative to conventional surgery or percutaneous interventions.
- The technique is also suitable for patients experiencing acute coronary events.
Background:
The aim of this study was to assess the feasibility of robotically enhanced myocardial revascularization and to present the clinical outcome of 196 patients.
Methods:
All internal thoracic arteries were harvested with the aid of a robotic surgical system. While off-pump revascularization techniques were mostly used, peripheral cardiopulmonary bypass was needed in some cases with multivessel disease.
Results:
A single (n = 118) or multivessel (n = 74) coronary revascularization was performed. Four patients had to be converted to median sternotomy. There was no operative mortality. Follow-up was complete in 88% (n = 169) patients. The rate of freedom from ischaemic symptoms was 98.2% at mean 22 +/- 3 months. Graft patency was 96.4% (81/84).
Conclusions:
By increasing surgical capabilities, robotically enhanced CABG in single or multivessel coronary disease was safe, effective and reasonable. It can be an alternative approach to percutaneous methods and conventional surgical techniques, or even used in acute coronary events.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018